Seven Bridge Financial Group, LLC Nevro Corp Transaction History

Seven Bridge Financial Group, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 09, 2019	SELL	$61.52 - $91.1 $2,891 - $4,281	-47 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$72.38 - $92.5 $4,849 - $6,197	-67 Reduced 58.77%	47 $4,000
Q1 2018 May 11, 2018	SELL	$69.46 - $88.57 $17,990 - $22,939	-259 Reduced 69.44%	114 $10,000
Q2 2017 Aug 14, 2017	BUY	N/A	373	373 $28,000

150

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $160M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Seven Bridge Financial Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Seven Bridge Financial Group, LLC with notifications on news.